Item 1(a). | Name of Issuer: |
SpringWorks Therapeutics, Inc. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
100 Washington Boulevard
Stamford, CT 06902
Item 2(a). | Name of Person Filing: |
This Schedule 13G is jointly filed by Boxer Capital, LLC (“Boxer Capital”), Boxer Asset Management Inc. (“Boxer Management”) and Joe Lewis (together with Boxer Capital and Boxer Management, the “Reporting Persons”). Boxer Management is the managing member and majority owner of Boxer Capital. Joe Lewis is the sole indirect beneficial owner of and controls Boxer Management.
Item 2(b). | Address of Principal Business Office, or, if none, Residence: |
The principal business address of Boxer Capital is: 12860 El Camino Real, Suite 300, San Diego, CA 92130. The principal business address of Boxer Management and Joe Lewis is: Cay House, EP Taylor Drive N7776, Lyford Cay, New Providence, Bahamas.
Boxer Capital is a limited liability company organized under the laws of Delaware. Boxer Management is a corporation organized under the laws of the Bahamas. Joe Lewis is a citizen of the United Kingdom.
Item 2(d). | Title of Class of Securities: |
Common stock, par value $0.0001 per share (the “Common Stock”)
85205L107
Item 3. | If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
| (a) | Amount beneficially owned: |
The Reporting Persons beneficially own 3,421,541 shares of Common Stock.
The number of shares of Common Stock beneficially owned by the Reporting Persons represent 5.7% of the Issuer’s outstanding Common Stock (based on 60,144,001 shares of Common Stock outstanding, which is the sum of (i) 49,442,662 shares of Common Stock outstanding as of July 29, 2022 as set forth in the Issuer’s Quarterly Report on Form 10-Q, filed with the SEC on August 4, 2022, (ii) 2,050,819 shares of Common Stock issued in a private placement, as described in the Issuer’s Current Report on Form 8-K, filed with the SEC on September 7, 2022, and (iii) 8,650,520 shares of Common Stock issued in a private placement, as described in the Issuer’s Current Report on Form 8-K, filed with the SEC on September 8, 2022).